Insert Footer or Copyright Information Here

Slides:



Advertisements
Similar presentations
Sleep / Rest for Older Adults. Objectives Describe the normal changes in sleep patters associated with age. Describe the normal changes in sleep patters.
Advertisements

Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
The FREEDOM Study (Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances) Source Jaber BL, Schiller B, Burkart JM, et al.
Sleep, Pain, and Fatigue in Ehlers-Danlos Syndrome Ehlers-Danlos National Foundation Learning Conference August 9, 2012 Susan Cordes, MS, CGC.
Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW) R. Phan Ba 1, 2, P. Calay 1, 2, P.
Depression—There are at least two sides to every story.
Clinical assessment Aims (1) Is it a stroke? (2) What part of the brain is affected? (3) What caused this stroke? Is it a haemorrhage or an infarct? Can.
Interpreting Sleep Study Reports: A Primer for Pulmonary Fellows
SLEEP STUDIES Written by: Melissa Dearing - LSC-Kingwood.
Friends With MS.com Bringing you support and information for Multiple Sclerosis.
Interpretation of Polysomnography
OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE By Ahmad Younis Professor.
Chair Timothy L. Vollmer, MD Professor of Neurology
Sleep Disorders
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
Assessment Approach Dr. Hunt. Areas of Assessment Basic Medical record Urgent Symptom Disease Symptom-based condition.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Quantitative EEG during Sleep in Fibromyalgia Victor Rosenfeld M.D. Director of Neurology, SouthCoast Medical Group Medical Director, SouthCoast Sleep.
MULTIPLE SCLEROSIS Ana Costas Barreiro.
Why studying neurosciences? Neurological symptoms account for high % of consultation in general practice. Accounts for 20% of acute admissions to hospitals,
1 Mosby items and derived items © 2010 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 19 Assessment of Sleep and Breathing.
Hala A. Shaheen Prof and head of neurology department, Faculty of medicine, Fayoum university.
General Concepts of Brain Organization with Relevance to Clinical Neurology Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of.
Multiple Sclerosis. What is MS? This is a chronic and often disabling disease in which the body’s immune system (t-cells) attacks the central nervous.
Orienting network dysfunction in progressive multiple sclerosis (ID 208) Chalah MA 1,2, Palm U 1,3, Nguyen R 1,4, Créange A 1,4, Lefaucheur JP 1,2, Ayache.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
Aim To identify common co-existing sleep disorders in childhood parasomnia and To assess sleep architecture in subgroup of children with parasomnia Introduction.
In The Name of God. Multiple Sclerosis and Normal MRI new modalities for problems solving.
Introduction to Neuroanatomy and Terminology. Main Regions of the Nervous System Two Main Divisions –Central Nervous System –Peripheral Nervous System.
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
Comorbid migraine in major depressive disorder suggests
Capturing the Costs of End-of-Life Care: Comparisons of Multiple Sclerosis, Parkinson's Disease, and Dementia  Paul McCrone, PhD  Journal of Pain and.
International Neurourology Journal 2015;19:
The influence of depression symptoms and sleep quality on the functional level of FMS patients I. Bouloukaki1, L. Konstantara1, C. Mermigkis1, E. Markakis2,
CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE AS AN ALTERNATIVE TREATMENT IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS Tania Gabriela Hernández Mojica. UNIVERSIDAD.
International Neurourology Journal 2016;20:
Evaluation of sleep architecture and functional level in Fibromyalgia patients with and without obstructive sleep apnea syndrome I. Bouloukaki1, L. Konstantara1,
How Neurological Disability Influences the Quality of Life in People With Multiple Sclerosis Luísa Pedro / José Luís Pais Ribeiro Escola Superior de Tecnologia.
Chlamydia pneumoniae-specific CSF-restricted oligoclonal IgG bands are associated to a subset of patients with progressive forms of Multiple Sclerosis.
Positive Impact of Regular Circuit Training on Muscle Strength, Stability, Depression and Fatigue in Multiple Sclerosis Patients Sucha L, Kalincik T, Novotna.
Associate Director, Biostatistics
Brief Computerized Measures of Information Processing Speed are Sensitive to Multiple Sclerosis across the Lifespan M. Shaw1, C. Schwarz1, L.B. Krupp1,
A 26-y.o. woman with RRMS and eruption of plaques.
PATIENT ACTIVATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
Nocturnal Periodic Leg Movements in
CORRELATION OF BIOMARKERS FOR AXONAL DEGENERATION WITH RETINAL NERVE FIBER LAYER THICKNESS AND DISABILITY IN DIFFERENT PHASES OF MULTIPLE SCLEROSIS UZUNKOPRU.
Cognitive Biomarker of MS
Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination  Yoko Warabi, Yoh Matsumoto, Hideaki Hayashi 
بسم الله الرحمن الرحيم.
Understanding the Brain
Sleep and Adhd The Link between Parent and Child Sleep Disturbances in Children with Attention Deficit Hyperactivity Disorder Dr. Martin Efron The Child.
PHYSICAL ACTIVITY AND DEPRESSION IN FIBROMYALGIA
SP 6200 Enthusiastic Studysnaptutorial.com
Cognitive Disorders and Aging
Renal disease progression in patients with TTR amyloidosis
High prevalence of anxiety symptoms in spouses of persons suffering from persons Ingun Ulstein*, Norwegian Centre for Dementia Research, Department of.
The Central Nervous System
Does a single diversity training day make a lasting impression?
Non-parametric tests, part A:
Functional Dyspepsia Is Associated With Sleep Disorders
Mental Health and Obstructive Sleep Apnea
Figure 1 Characteristics of the German National MS Cohort
Figure 1 Levels of miR-150 are elevated in patients with multiple sclerosis (MS) and patients with clinically isolated syndrome (CIS) who convert to MS.
Figure 4 Four representative disease-course archetypes
Couple therapy for depression –effectiveness monitoring
Analysis of demographic and pathophysiological data among sleepy and non- sleepy adult OSA patients in Parami General Hospital in Parami General Hospital.
Impact of approaches for clinical and radiological monitoring on predicting of short-term and long-term disability outcomes in multiple sclerosis Brian.
Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis  Christine Riedhammer,
Presentation transcript:

Insert Footer or Copyright Information Here Assessment Of Sleep Disorders In Remitting-Relapsing Multiple Sclerosis Patients J.F. Mekky, H.O. Sadallah, A. Elkersh, F.M. Marei Neuropsychiatry, faculty of medicine Alexandria University, Alexandria, Egypt Replace with logo Replace with logo Subjects Background Methods RESULTS It was conducted upon 30 subjects who were divided into two groups: · Group of multiple sclerosis patients: 15 patients · Group of healthy individuals: 15 individual MRI lesions Informed Consent was taken from every participate. · History taking, general and neurological examination. · Assessment of MS severity by expanded disability scoring scale (EDSS). . · MRI brain and posterior fossa. · Overnight polysomnography. Multiple sclerosis is a chronic degenerative inflammatory disease of the central nervous system with a wide range of signs and symptoms, including neurological, menta and sleep disorders . One puzzling aspect of MS for clinicians and researchers alike is the nature of the relation between sleep disorders and MS. Comparing the pateint and control group sleep studies there was a difference in the sleep efficiency , which was significantly lower among the MS patients (p < 0.001 ). The sleep latency was longer , the arousal index and the total sleep change were higher also in the patient group .MRI findings in 13 patients who had longer sleep latency and , were plaques at centrum semioval, corona radiate, forceps major, periventricular parietal, cerebellum, pons, medulla and spinal cord. There was an evident statistically significant difference between the two group regarding the sleep stages . The MS patients had longer stage one, two and REM sleep but significantly shorter deep sleep .REM latency was also significantly higher amaong pateints .MRI findings in 5 patients who had decreased REM sleep% and latency were plaques at centrum semioval, periventricular parietal and pons. Objective CONCLUSION Relation between duration of illness with different studied parameters in patients group χ2: Chi square for Kruskal Wallis test p1: p value for Mann Whitney test for comparing between 1 – 3 category and each other category p2: p value for Mann Whitney test for comparing between 3 – 5 with ≥5 category *: Statistically significant at p ≤ 0.05   Duration of illness χ2 p 1 - 3 (n=4) 3 - 5 (n=7) ≥5 (n=4) Total stages changes Min. – Max. 35.0 – 61.0 49.0 – 97.0 58.0 – 164.0 6.663* 0.036* Mean ± SD. 45.25 ± 11.27 72.29 ± 19.01 98.50 ± 47.93 Median 42.50 75.0 86.0 p1 0.023* 0.043* p2 0.345 Arousal index 8.0 – 37.0 25.0 – 95.0 45.0 – 98.0 5.767 0.056 25.25 ± 12.37 62.43 ± 25.36 70.50 ± 22.75 28.0 66.0 69.50 0.058 0.021* 0.705 REM latency 100.0 – 122.0 80.0 – 175.0 17.0 – 179.0 1.521 0.467 109.50 ± 9.47 125.57±33.12 93.25 ± 68.86 108.0 129.0 88.50 AHI 0.0 – 2.0 1.0 – 81.0 1.0 – 30.0 3.718 0.156 0.75 ± 0.96 16.86 ± 28.77 8.50 ± 14.34 0.50 10.0 1.50 Snoring index 16.0 – 48.0 17.0 – 250.0 218.0 – 1042.0 8.314* 0.016* 30.25 ± 13.28 82.71 ± 83.13 469.75 ± 389.8 28.50 47.0 309.5 0.131 PL index 0.0 - 0.0 0.0 – 1.0 2.0 – 6.0 10.650* 0.005* 0.0 ± 0.0 0.43 ± 0.53 3.25 ± 1.89 0.0 2.50 0.143 0.013* 0.006* To study the sleep disorders in clinically definite RRMS patients during remission as regard the duration of illness , the EDSS score and the sites of The apnea hypopnea index, snoring index , denoting higher chance of sleep disordered breathing during the course of the illness.MRI findings in 3 patients who had Sleep-disordered breathing were plaques at centrum semioval, periventricular parietal, cerebellum and medulla. The periodic limb movements index was also significantly higher in MS pateints.6 patients who had PLMD had plaques at centrum semioval, periventricular parietal, cerebellum, spinal cord and optic nerve.   MFIS Z p <38 (n=5) ≥38 (n=10) Total stages changes Min. – Max. 35.0 – 61.0 49.0 – 164.0 2.694* 0.007* Mean ± SD. 46.20 ± 9.98 85.0 ± 32.82 Median 45.0 80.50 Arousal index 8.0 – 37.0 34.0 – 98.0 2.942* 0.003* 25.20 ± 10.71 69.40 ± 20.51 26.0 66.0 REM latency 90.0 – 122.0 17.0 – 179.0 0.982 0.326 105.60 ± 11.97 116.20 ± 50.38 105.0 125.50 AHI 0.0 – 2.0 1.0 – 81.0 2.091* 0.037* 0.80 ± 0.84 15.10 ± 24.90 1.0 6.0 Snoring index 16.0 – 48.0 34.0 – 1042.0 27.60 ± 12.93 244.10 ± 303.99 27.0 177.50 PL index 0.0 - 0.0 0.0 – 6.0 2.337* 0.019* 0.0 ± 0.0 1.60 ± 1.84 0.0 patients group Z: Z for Mann Whitney test *: Statistically significant at p ≤ 0.05 Relation between BDI with demographic data in patients group Of 15patients ,3 were normal according to BDI (≤10) and 12 were with mood changes(>10),one had mild mood disturbance ,2 had borderline clinical depression and 10 had moderate depression(score21-30 Sleep disorders are common in MS and should be screened for carefully in all MS patients,taking into consideration sites of the lesion, duration of illness or EDSS score . References Journal Article, Name of Journal Insert Footer or Copyright Information Here Printed by